{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:33:15Z","timestamp":1792855995989,"version":"4.5.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.vph.2026.107685","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:34:06Z","timestamp":1786034046000},"page":"107685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An explicative review on Diabetic Cardiac Autonomic Neuropathy: From pathophysiology to the era of gene therapy"],"prefix":"10.1016","volume":"164","author":[{"given":"Rudra","family":"Chakravarti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal Ramesh","family":"Bankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhanshi","family":"Chigilipalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipanjan","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bireswar","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya Kumar","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipanjan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2026.107685_bb0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/B978-0-444-64032-1.00027-8","article-title":"Basics of autonomic nervous system function","volume":"160","author":"Gibbons","year":"2019","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0010","first-page":"25","article-title":"Rehabilitation of peripheral neuropathies","volume":"2","author":"Berger","year":"1988","journal-title":"J. Neurol. Rehab."},{"key":"10.1016\/j.vph.2026.107685_bb0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/B978-0-444-52902-2.00033-3","article-title":"Diabetic neuropathy","volume":"115","author":"Said","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ncl.2013.02.004","article-title":"Diabetic neuropathy part 1: overview and symmetric phenotypes","volume":"31","author":"Pasnoor","year":"2013","journal-title":"Neurol. Clin."},{"issue":"Supplement_2","key":"10.1016\/j.vph.2026.107685_bb0025","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.2337\/diab.46.2.S54","article-title":"Classification, differential diagnosis, and staging of diabetic peripheral neuropathy","volume":"46","author":"Thomas","year":"1997","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.vph.2026.107685_bb0030","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/qjmed\/77.3.1209","article-title":"Natural history of the diabetic neuropathies","volume":"77","author":"Watkins","year":"1990","journal-title":"QJM Int. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0035","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4093\/dmj.2018.0259","article-title":"Update on the impact, diagnosis and management of cardiovascular autonomic neuropathy in diabetes: what is defined, what is new, and what is unmet","volume":"43","author":"Spallone","year":"2019","journal-title":"Diabetes Metab. J."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v9.i1.1","article-title":"Cardiac autonomic neuropathy: risk factors, diagnosis and treatment","volume":"9","author":"Serhiyenko","year":"2018","journal-title":"World J. Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2337\/dc16-1397","article-title":"Cardiovascular autonomic neuropathy and cardiovascular outcomes in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications (DCCT\/EDIC) study","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"issue":"25","key":"10.1016\/j.vph.2026.107685_bb0055","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Control","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0060","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2337\/dc15-0466","article-title":"Effect of low-energy diets differing in fiber, red meat, and coffee intake on cardiac autonomic function in obese individuals with type 2 diabetes","volume":"38","author":"Ziegler","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.dsx.2017.08.015","article-title":"Exercise training and cardiac autonomic function in type 2 diabetes mellitus: a systematic review","volume":"12","author":"Bhati","year":"2018","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"12","key":"10.1016\/j.vph.2026.107685_bb0070","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"The Diabetes Prevention Program (DPP) description of lifestyle intervention","volume":"25","author":"Group, D.P.P.R","year":"2002","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.vph.2026.107685_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154211","article-title":"Bariatric surgery restores cardiac and sudomotor autonomic C-fiber dysfunction towards normal in obese subjects with type 2 diabetes","volume":"11","author":"Casellini","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vph.2026.107685_bb0080","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s13300-019-00693-0","article-title":"Cardiac autonomic neuropathy in obesity, the metabolic syndrome and prediabetes: a narrative review","volume":"10","author":"Williams","year":"2019","journal-title":"Diab. Therapy"},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0085","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00125-020-05316-z","article-title":"The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review","volume":"64","author":"Eleftheriadou","year":"2021","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0090","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1464-5491.1993.tb00173.x","article-title":"Mortality in diabetic patients with cardiovascular autonomic neuropathy","volume":"10","author":"Rathmann","year":"1993","journal-title":"Diabet. Med."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0095","doi-asserted-by":"crossref","first-page":"e2434622","DOI":"10.1001\/jamanetworkopen.2024.34622","article-title":"Incidence, prevalence, and survival of prostate cancer in the UK","volume":"7","author":"Tan","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"21","key":"10.1016\/j.vph.2026.107685_bb0100","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/jnci\/88.21.1571","article-title":"Recent trends in US breast cancer incidence, survival, and mortality rates","volume":"88","author":"Chu","year":"1996","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.vph.2026.107685_bb0105","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-016-4065-6","article-title":"Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial","volume":"59","author":"G\u00e6de","year":"2016","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.vph.2026.107685_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119352","article-title":"Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections","volume":"24","author":"Gonz\u00e1lez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0115","article-title":"Understanding diabetic neuropathy: focus on oxidative stress","volume":"2020","author":"Pang","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/1673-5374.177745","article-title":"Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway","volume":"11","author":"Li","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0125","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.vph.2026.107685_bb0130","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nm.2750","article-title":"Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy","volume":"18","author":"Bierhaus","year":"2012","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.vph.2026.107685_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077986","article-title":"Methylglyoxal evokes pain by stimulating TRPA1","volume":"8","author":"Andersson","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.112.192112","article-title":"Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism","volume":"342","author":"Dhar","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"33","key":"10.1016\/j.vph.2026.107685_bb0145","doi-asserted-by":"crossref","first-page":"55039","DOI":"10.18632\/oncotarget.18993","article-title":"Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.vph.2026.107685_bb0150","article-title":"AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration","volume":"16\u20132023","author":"Bhattacharya","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0155","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2174\/1871527313666140806144831","article-title":"Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress","volume":"13","author":"T\u00f3bon-Velasco","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.vph.2026.107685_bb0160","doi-asserted-by":"crossref","first-page":"6809703","DOI":"10.1155\/2016\/6809703","article-title":"The role of AGE\/RAGE signaling in diabetes-mediated vascular calcification","volume":"2016","author":"Kay","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s109-1998-8101-y","article-title":"Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus","volume":"76","author":"Ishii","year":"1998","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.vph.2026.107685_bb0170","doi-asserted-by":"crossref","first-page":"1618343","DOI":"10.3389\/fcvm.2025.1618343","article-title":"Protein kinase C and endothelial dysfunction in select vascular diseases","volume":"12","author":"Kant","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.vph.2026.107685_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107512","article-title":"Mapping and refactoring pathway control through metabolic and protein engineering: the hexosamine biosynthesis pathway","volume":"40","author":"Coussement","year":"2020","journal-title":"Biotechnol. Adv."},{"issue":"12","key":"10.1016\/j.vph.2026.107685_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122635","article-title":"Fructose metabolism in cancer","volume":"9","author":"Krause","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.vph.2026.107685_bb0185","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-01755-x","article-title":"Metabolic memory: mechanisms and diseases","volume":"9","author":"Dong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.vph.2026.107685_bb0195","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1002\/mco2.651","article-title":"Endothelial dysfunction: molecular mechanisms and clinical implications","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0200","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034173","article-title":"Vagus nerve stimulation and the cardiovascular system","volume":"10","author":"Capilupi","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.vph.2026.107685_bb0205","article-title":"Autonomic neurotransmission in cardiovascular regulation and pathophysiology","volume":"19","author":"Varzideh","year":"2025","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/europace\/eum286","article-title":"Cardiac repolarization during hypoglycaemia and hypoxaemia in healthy males: impact of renin-angiotensin system activity","volume":"10","author":"Due-Andersen","year":"2008","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.vph.2026.107685_bb0215","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/CIRCULATIONAHA.107.726067","article-title":"Cardiac autonomic dysfunction: effects from particulate air pollution and protection by dietary methyl nutrients and metabolic polymorphisms","volume":"117","author":"Baccarelli","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1262-3636(07)70248-3","article-title":"The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients","volume":"32","author":"Chistiakov","year":"2006","journal-title":"Diabetes Metab."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ahj.2007.03.053","article-title":"Association of beta-adrenoceptor polymorphisms with cardiac autonomic modulation in Japanese males","volume":"154","author":"Matsunaga","year":"2007","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0230","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1523-1755.2000.00876.x","article-title":"Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension","volume":"57","author":"Pontremoli","year":"2000","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0235","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/diseases13090289","article-title":"Angiotensin-converting enzyme gene polymorphisms and diabetic neuropathy: insights from a scoping review and scientometric analysis","volume":"13","author":"Melo","year":"2025","journal-title":"Diseases"},{"issue":"26","key":"10.1016\/j.vph.2026.107685_bb0245","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1073\/pnas.261469998","article-title":"Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase","volume":"98","author":"Yamada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vph.2026.107685_bb0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mvr.2018.03.012","article-title":"Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?","volume":"119","author":"Yuyun","year":"2018","journal-title":"Microvasc. Res."},{"issue":"32","key":"10.1016\/j.vph.2026.107685_bb0255","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.2174\/0929867321666140706142335","article-title":"Endothelial dysfunction: the link between homocysteine and hydrogen sulfide","volume":"21","author":"Pushpakumar","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0260","article-title":"A comprehensive review of free radicals, oxidative stress, and antioxidants: overview, clinical applications, global perspectives, future directions, and mechanisms of antioxidant activity of flavonoid compounds","volume":"2024","author":"Tumilaar","year":"2024","journal-title":"J. Chem."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.advms.2015.10.006","article-title":"Genetic polymorphisms (Pro197Leu of Gpx1,+ 35A\/C of SOD1,\u2212 262C\/T of CAT), the level of antioxidant proteins (GPx1, SOD1, CAT) and the risk of distal symmetric polyneuropathy in Polish patients with type 2 diabetes mellitus","volume":"61","author":"Kasznicki","year":"2016","journal-title":"Adv. Med. Sci."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26041765","article-title":"ADRB2 polymorphisms (rs1042713 and rs1042714) and blood pressure response to the cold pressor test in combat athletes and non-athletes","volume":"26","author":"Sawczuk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.vph.2026.107685_bb0275","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00592-012-0418-x","article-title":"TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy","volume":"50","author":"Ciccacci","year":"2013","journal-title":"Acta Diabetol."},{"issue":"3","key":"10.1016\/j.vph.2026.107685_bb0280","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1073858407305725","article-title":"TNFalpha: a trigger of autonomic dysfunction","volume":"14","author":"Hermann","year":"2008","journal-title":"Neuroscientist"},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0290","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/hmg\/ddac309","article-title":"Biochemical characterization of two novel mutations in the human high-affinity choline transporter 1 identified in a patient with congenital myasthenic syndrome","volume":"32","author":"Rizvi","year":"2023","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0295","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1440-1681.2004.04059.x","article-title":"T393C polymorphism of GNAS1 associated with the autonomic nervous system in young, healthy Japanese subjects","volume":"31","author":"Yasuda","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0300","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12872-024-03912-0","article-title":"Genetic markers of cardiac autonomic neuropathy in the Kazakh population","volume":"24","author":"Bekenova","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.vph.2026.107685_bb0305","article-title":"Association between the FTO gene variant rs9939609 and obesity risk: a case-control study","volume":"21","author":"Haq","year":"2026","journal-title":"End. Metab. Sci."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0310","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1038\/s41467-019-12332-0","article-title":"Pparg promotes differentiation and regulates mitochondrial gene expression in bladder epithelial cells","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vph.2026.107685_bb0315","article-title":"Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson\u2019s disease","volume":"12\u20132018","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"issue":"15","key":"10.1016\/j.vph.2026.107685_bb0320","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1093\/nar\/gkn480","article-title":"XRCC1 protects against the lethality of induced oxidative DNA damage in nondividing neural cells","volume":"36","author":"Kulkarni","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0325","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00592-014-0582-2","article-title":"Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes","volume":"51","author":"Ciccacci","year":"2014","journal-title":"Acta Diabetol."},{"issue":"5532","key":"10.1016\/j.vph.2026.107685_bb0330","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.293.5532.1103","article-title":"Genes, genetics, and epigenetics: a correspondence","volume":"293","author":"Wu","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0335","first-page":"275","article-title":"Epigenetic silencing of tumor suppressor genes: paradigms, puzzles, and potential","volume":"1865","author":"Kazanets","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0340","doi-asserted-by":"crossref","first-page":"C570","DOI":"10.1152\/ajpcell.00201.2022","article-title":"Epigenetic modifications in metabolic memory: what are the memories, and can we erase them?","volume":"323","author":"Chen","year":"2022","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.vph.2026.107685_bb0345","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neubiorev.2021.02.040","article-title":"Epigenetics of the developing and aging brain: mechanisms that regulate onset and outcomes of brain reorganization","volume":"125","author":"Bacon","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.vph.2026.107685_bb0350","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.apsb.2013.04.007","article-title":"Epigenetic modification enzymes: catalytic mechanisms and inhibitors","volume":"3","author":"Lu","year":"2013","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0355","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.pain.2013.05.021","article-title":"HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain","volume":"154","author":"Denk","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.vph.2026.107685_bb0360","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918798408","article-title":"The etiological changes of acetylation in peripheral nerve injury-induced neuropathic hypersensitivity","volume":"14","author":"Wang","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.vph.2026.107685_bb0365","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4065382","article-title":"Histone acetylation and its modifiers in the pathogenesis of diabetic nephropathy","volume":"2016","author":"Li","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"7","key":"10.1016\/j.vph.2026.107685_bb0370","article-title":"Inhibition of HDAC6 attenuates diabetes-induced retinal redox imbalance and microangiopathy","volume":"9","author":"Abouhish","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"7","key":"10.1016\/j.vph.2026.107685_bb0375","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1096\/fj.201900127R","article-title":"STAT3 phosphorylation mediates high glucose\u2014impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy","volume":"33","author":"Du","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2026.107685_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9494052","article-title":"Inhibition of HDAC6 activity alleviates myocardial ischemia\/reperfusion injury in diabetic rats: potential role of peroxiredoxin 1 acetylation and redox regulation","volume":"2018","author":"Leng","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.vph.2026.107685_bb0385","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1681\/ASN.2010060633","article-title":"Epigenetic histone methylation modulates fibrotic gene expression","volume":"21","author":"Sun","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"34","key":"10.1016\/j.vph.2026.107685_bb0390","doi-asserted-by":"crossref","first-page":"12695","DOI":"10.1074\/jbc.RA119.007575","article-title":"Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-\u03b21-induced gene expression in mesangial cells and diabetic kidney","volume":"294","author":"Jia","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.vph.2026.107685_bb0395","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.bjp.0707666","article-title":"Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy","volume":"153","author":"Tikoo","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2026.107685_bb0400","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/589474","article-title":"Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells","volume":"2013","author":"Gao","year":"2013","journal-title":"J. Diabetes Res."},{"issue":"21","key":"10.1016\/j.vph.2026.107685_bb0405","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1042\/BCJ20160595","article-title":"Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7\/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis","volume":"473","author":"Goru","year":"2016","journal-title":"Biochem. J."},{"issue":"26","key":"10.1016\/j.vph.2026.107685_bb0410","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.0803623105","article-title":"Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes","volume":"105","author":"Villeneuve","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.vph.2026.107685_bb0415","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/db08-1666","article-title":"Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail","volume":"58","author":"Brasacchio","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2026.107685_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2020.101345","article-title":"\u03b2-Hydroxybutyrate antagonizes aortic endothelial injury by promoting generation of VEGF in diabetic rats","volume":"64","author":"Wu","year":"2020","journal-title":"Tissue Cell"},{"issue":"12","key":"10.1016\/j.vph.2026.107685_bb0425","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00592-020-01552-2","article-title":"Up-regulation of MMP-2 by histone H3K9 \u03b2-hydroxybutyrylation to antagonize glomerulosclerosis in diabetic rat","volume":"57","author":"Luo","year":"2020","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.vph.2026.107685_bb0430","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7643322","article-title":"Sodium butyrate attenuates diabetic kidney disease partially via histone butyrylation modification","volume":"2022","author":"Zhou","year":"2022","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1403","article-title":"Identification of histone malonylation in the human fetal brain and implications for diabetes-induced neural tube defects","volume":"8","author":"Zhang","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0440","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41467-021-27572-2","article-title":"Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer\u2019s disease","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0445","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2217\/epi-2020-0273","article-title":"The growing landscape of succinylation links metabolism and heart disease","volume":"13","author":"Yang","year":"2021","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0450","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.vph.2026.107685_bb0455","article-title":"Tet enzymes, variants, and differential effects on function","volume":"6\u20132018","author":"Melamed","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.vph.2026.107685_bb0460","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/EBC20190030","article-title":"Enhancer DNA methylation: implications for gene regulation","volume":"63","author":"Angeloni","year":"2019","journal-title":"Essays Biochem."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0465","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12033-009-9216-2","article-title":"DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker","volume":"44","author":"Tost","year":"2010","journal-title":"Mol. Biotechnol."},{"issue":"8","key":"10.1016\/j.vph.2026.107685_bb0470","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s42255-020-0231-8","article-title":"DNA methylation mediates development of HbA1c-associated complications in type 1 diabetes","volume":"2","author":"Chen","year":"2020","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0475","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13148-020-00840-6","article-title":"DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes","volume":"12","author":"Roshandel","year":"2020","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0480","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13148-021-01081-x","article-title":"Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study","volume":"13","author":"Smyth","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"8","key":"10.1016\/j.vph.2026.107685_bb0485","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/dme.12775","article-title":"Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with type 1 diabetes","volume":"32","author":"Swan","year":"2015","journal-title":"Diabet. Med."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0490","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/epi.6.1.13362","article-title":"DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy","volume":"6","author":"Sapienza","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.vph.2026.107685_bb0495","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12916-015-0421-5","article-title":"Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy","volume":"13","author":"Agardh","year":"2015","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.vph.2026.107685_bb0500","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1167\/iovs.12-9732","article-title":"Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy","volume":"53","author":"Tewari","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0505","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12020-019-02172-9","article-title":"Epigenetic mechanism in search for the pathomechanism of diabetic neuropathy development in diabetes mellitus type 1 (T1DM)","volume":"68","author":"Gasto\u0142","year":"2020","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0510","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jdi.12988","article-title":"Genetic variants in DNMT1 and the risk of cardiac autonomic neuropathy in women with type 1 diabetes","volume":"10","author":"Santos-Bezerra","year":"2019","journal-title":"J. Diab. Investig."},{"issue":"10","key":"10.1016\/j.vph.2026.107685_bb0515","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.4161\/15592294.2014.967584","article-title":"Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts","volume":"9","author":"Park","year":"2014","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0520","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2337\/db11-0588","article-title":"Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression","volume":"61","author":"Olsen","year":"2012","journal-title":"Diabetes"},{"issue":"22","key":"10.1016\/j.vph.2026.107685_bb0525","article-title":"Hyperglycemic memory in the rat bladder detrusor is associated with a persistent hypomethylated state","volume":"8","author":"Wang","year":"2020","journal-title":"Phys. Rep."},{"issue":"6921","key":"10.1016\/j.vph.2026.107685_bb0530","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature01411","article-title":"Controlling the double helix","volume":"421","author":"Felsenfeld","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vph.2026.107685_bb0535","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0168-8227(09)70002-6","article-title":"Hypothesis: the \u201cmetabolic memory\u201d, the new challenge of diabetes","volume":"86","author":"Ceriello","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0540","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.dsx.2016.03.016","article-title":"Metabolic memory phenomenon in diabetes mellitus: achieving and perspectives","volume":"10","author":"Berezin","year":"2016","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"issue":"5","key":"10.1016\/j.vph.2026.107685_bb0545","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up","volume":"39","author":"Control, D., C.T.E.o.D. Interventions, and C.S.R. Group","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2026.107685_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.725532","article-title":"Molecular mechanisms and epigenetic regulation in diabetic cardiomyopathy","volume":"8","author":"Mittal","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094589","article-title":"Epigenetic modifications and non-coding RNA in diabetes-mellitus-induced coronary artery disease: pathophysiological link and new therapeutic frontiers","volume":"23","author":"Prandi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2026.107685_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.907060","article-title":"Emerging role of epitranscriptomics in diabetes mellitus and its complications","volume":"13","author":"Geng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.vph.2026.107685_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.702579","article-title":"Changes in N6-Methyladenosine modification modulate diabetic cardiomyopathy by reducing myocardial fibrosis and myocyte hypertrophy","volume":"9","author":"Ju","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0570","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","article-title":"METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA","volume":"13","author":"Meng","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0575","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12026-025-09702-w","article-title":"METTL14 aggravates pyroptosis in diabetic cardiomyopathy by promoting m6A modification of NLRP3","volume":"73","author":"Hua","year":"2025","journal-title":"Immunol. Res."},{"issue":"3","key":"10.1016\/j.vph.2026.107685_bb0580","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/dc16-0173","article-title":"Circulating modified metabolites and a risk of ESRD in patients with type 1 diabetes and chronic kidney disease","volume":"40","author":"Niewczas","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2026.107685_bb0585","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jpba.2018.10.042","article-title":"Succinic acid enhanced quantitative determination of blood modified nucleosides in the development of diabetic nephropathy based on hydrophilic interaction liquid chromatography mass spectrometry","volume":"164","author":"Guo","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0590","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s10020-021-00365-5","article-title":"METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of \u03b1-klotho","volume":"27","author":"Li","year":"2021","journal-title":"Mol. Med."},{"issue":"10","key":"10.1016\/j.vph.2026.107685_bb0595","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41419-021-04156-y","article-title":"METTL14 aggravates podocyte injury and glomerulopathy progression through N(6)-methyladenosine-dependent downregulating of Sirt1","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0600","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7150\/thno.63441","article-title":"METTL3-mediated N(6)-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication","volume":"12","author":"Suo","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.vph.2026.107685_bb0605","article-title":"ALKBH5-mediated m(6)a modification of A20 regulates microglia polarization in diabetic retinopathy","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vph.2026.107685_bb0610","doi-asserted-by":"crossref","DOI":"10.1186\/1756-6606-7-5","article-title":"A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia","volume":"7","author":"Kubota-Sakashita","year":"2014","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0615","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41583-019-0244-z","article-title":"The m6A epitranscriptome: transcriptome plasticity in brain development and function","volume":"21","author":"Livneh","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/genes10010052","article-title":"Epitranscriptomic signatures in lncRNAs and their possible roles in cancer","volume":"10","author":"Dinescu","year":"2019","journal-title":"Genes"},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0625","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3892\/ijo.2025.5735","article-title":"Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis","volume":"66","author":"Dai","year":"2025","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0630","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094887","article-title":"Genetic and epigenomic modifiers of diabetic neuropathy","volume":"22","author":"Jankovic","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.173","article-title":"Targeting epigenetic regulators for inflammation: mechanisms and intervention therapy","volume":"3","author":"Zhang","year":"2022","journal-title":"MedComm"},{"issue":"27","key":"10.1016\/j.vph.2026.107685_bb0640","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1073\/pnas.1507882112","article-title":"PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3","volume":"112","author":"Salameh","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0645","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12035-015-9632-1","article-title":"lncRNA NONRATT021972 siRNA decreases diabetic neuropathic pain mediated by the P2X3 receptor in dorsal root ganglia","volume":"54","author":"Peng","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0650","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13041-016-0226-2","article-title":"LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia","volume":"9","author":"Liu","year":"2016","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0655","first-page":"2941297","article-title":"LncRNA NONRATT021972 was associated with neuropathic pain scoring in patients with type 2 diabetes","volume":"2017","author":"Yu","year":"2017","journal-title":"Behav. Neurol."},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0660","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11302-015-9488-x","article-title":"LncRNA uc. 48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia","volume":"12","author":"Wang","year":"2016","journal-title":"Purinergic Signal"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0665","article-title":"Effects of LncRNA BC168687 siRNA on diabetic neuropathic pain mediated by P2X7 receptor on SGCs in DRG of rats","volume":"2017","author":"Liu","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.vph.2026.107685_bb0670","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuroscience.2018.01.049","article-title":"Long non-coding RNA BC168687 is involved in TRPV1-mediated diabetic neuropathic pain in rats","volume":"374","author":"Liu","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.vph.2026.107685_bb0675","article-title":"Long non-coding RNA XIST attenuates diabetic peripheral neuropathy by inducing autophagy through MicroRNA-30d-5p\/s irtuin1 Axis","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.vph.2026.107685_bb0680","article-title":"Relationship of serum lncRNA XIST and miR-30d-5p levels with diabetic peripheral neuropathy in type 2 diabetes","volume":"14","author":"Wang","year":"2022","journal-title":"Am. J. Transl. Res."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0685","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1007\/s12035-022-02925-0","article-title":"LncRNA-UC. 25+ shRNA alleviates P2Y14 receptor\u2013mediated diabetic neuropathic pain via STAT1","volume":"59","author":"Wu","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.vph.2026.107685_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09178","article-title":"The axis of long non-coding RNA MALAT1\/miR-1-3p\/CXCR4 is dysregulated in patients with diabetic neuropathy","volume":"8","author":"Ashjari","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0695","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/dc13-2114","article-title":"Neuropathy and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Martin","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0700","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.vph.2026.107685_bb0705","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0710","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/diacare.29.04.06.dc05-1729","article-title":"The association among autonomic nervous system function, incident diabetes, and intervention arm in the diabetes prevention program","volume":"29","author":"Carnethon","year":"2006","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.vph.2026.107685_bb0715","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0720","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.vph.2026.107685_bb0725","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10193","key":"10.1016\/j.vph.2026.107685_bb0730","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.vph.2026.107685_bb0735","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10157","key":"10.1016\/j.vph.2026.107685_bb0740","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.vph.2026.107685_bb0745","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.vph.2026.107685_bb0750","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.vph.2026.107685_bb0755","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.vph.2026.107685_bb0760","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s00125-024-06242-0","article-title":"Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management","volume":"67","author":"Eleftheriadou","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.vph.2026.107685_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2015.00069","article-title":"Effect of mediterranean diet in diabetes control and cardiovascular risk modification: a systematic review","volume":"3","author":"Sleiman","year":"2015","journal-title":"Front. Public Health"},{"key":"10.1016\/j.vph.2026.107685_bb0770","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0026-0495(03)00213-0","article-title":"Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study","volume":"52","author":"Pedersen","year":"2003","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.vph.2026.107685_bb0775","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s13340-023-00629-x","article-title":"Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: a systematic review","volume":"14","author":"Goh","year":"2023","journal-title":"Diabetol. Int."},{"issue":"11","key":"10.1016\/j.vph.2026.107685_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/nu12113254","article-title":"Efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, and carnitine for 12 months in patients with diabetic neuropathy","volume":"12","author":"Didangelos","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0785","first-page":"201","article-title":"Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy","volume":"53","author":"Athyros","year":"1998","journal-title":"Acta Cardiol."},{"issue":"12","key":"10.1016\/j.vph.2026.107685_bb0790","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012307","article-title":"Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trial","volume":"6","author":"Hjortkj\u00e6r","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.vph.2026.107685_bb0795","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2337\/diacare.20.3.355","article-title":"Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy","volume":"20","author":"Kontopoulos","year":"1997","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.vph.2026.107685_bb0800","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/FOC.2009.26.2.E3","article-title":"The role of neurotrophic factors in nerve regeneration","volume":"26","author":"Gordon","year":"2009","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.vph.2026.107685_bb0805","article-title":"Evaluating the efficacy of mesenchymal stem cells for diabetic neuropathy: a systematic review and meta-analysis of preclinical studies","volume":"12","author":"Li","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"15","key":"10.1016\/j.vph.2026.107685_bb0810","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/WNR.0000000000001105","article-title":"Effect of Mito-TEMPO, a mitochondria-targeted antioxidant, in rats with neuropathic pain","volume":"29","author":"Zhan","year":"2018","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.vph.2026.107685_bb0815","doi-asserted-by":"crossref","first-page":"2451804","DOI":"10.1080\/09546634.2025.2451804","article-title":"Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review","volume":"36","author":"Liu","year":"2025","journal-title":"J. Dermatol. Treat."},{"issue":"19","key":"10.1016\/j.vph.2026.107685_bb0820","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910395","article-title":"Update on biomarkers of chronic inflammatory processes underlying diabetic neuropathy","volume":"25","author":"Stoian","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.vph.2026.107685_bb0825","article-title":"Chronic inflammation: a multidisciplinary analysis of shared pathways in autoimmune, infectious, and degenerative diseases","volume":"17","author":"Yacine","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.vph.2026.107685_bb0830","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nbd.2014.01.001","article-title":"PGC-1\u03b1 regulation of mitochondrial degeneration in experimental diabetic neuropathy","volume":"64","author":"Choi","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.vph.2026.107685_bb0835","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.redox.2016.08.013","article-title":"CRISPR\/Cas9-mediated knockout of p22phox leads to loss of Nox1 and Nox4, but not Nox5 activity","volume":"9","author":"Prior","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.vph.2026.107685_bb0840","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/bs.pmbts.2023.02.005","article-title":"CRISPR-dCas9 system for epigenetic editing towards therapeutic applications","volume":"198","author":"Bhattacharjee","year":"2023","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"8","key":"10.1016\/j.vph.2026.107685_bb0845","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/1389450123666220117105531","article-title":"A review on CRISPR-mediated epigenome editing: a future directive for therapeutic management of Cancer","volume":"23","author":"Chakravarti","year":"2022","journal-title":"Curr. Drug Targets"},{"issue":"11","key":"10.1016\/j.vph.2026.107685_bb0850","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1007\/s12033-023-00932-7","article-title":"Exosomes for CRISPR-Cas9 delivery: the cutting edge in genome editing","volume":"66","author":"Aslan","year":"2024","journal-title":"Mol. Biotechnol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:28:49Z","timestamp":1788578929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189126001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":170,"alternative-id":["S1537189126001059"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2026.107685","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An explicative review on Diabetic Cardiac Autonomic Neuropathy: From pathophysiology to the era of gene therapy","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2026.107685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107685"}}